Hikma Pharmaceuticals Share Discussion Threads

[robertball] 17/1/2022 10:22

GSK might be in the hunt once consumer side spun out / or sold to ULVR

[montyhedge] 17/1/2022 09:45

Should be 2800p but it's the Cinderella of the pharmaceutical sector, but making acquisitions every month it's seems. Low pe for a pharma, another dividend increase next month, that's 15th increase on the trot.I would not mind betting someone goes for Hikma.

[robertball] 17/1/2022 08:14

Indeed. Surely this should be £30. Value trap?

[montyhedge] 17/1/2022 08:11

Another acquisition, at least they keep growing.

[montyhedge] 14/1/2022 15:29

Figures next months 16 years continuous increased dividends on it way.

[cumnor] 14/1/2022 11:01

Just bought a few of those for the SIPP and long term-decent business and lowly valued, esp given its growing North American portfolio. The market, however, is tiring of these solid, profitable, cash generative businesses which pay the mgmt and board very highly but always seem to find an excuse (expansion, debt, investment etc) not to pay a more generous dividend. The days of investors paying £20+ for a share with a measly dividend-Hikma is not a growth share in the tech sense,it is a profitable and growing semi mature business-are gone and so the dividend should be moderately higher here. Let's hope mgmt address this issue.

[thamestrader] 13/1/2022 15:46

I have replaced the emergency glass cover over the 'buy' button, and tightened the screws.

[thamestrader] 13/1/2022 08:48

Wouldn't it be nice if this little tick-up marked the end, or at least the beginning of the end, of the relentless decline. Here's hoping.

Finger poised near 'buy' button.

[pdt] 13/1/2022 08:39

I have just bought my first shares here. Hopefully, I am not catching a falling knife!

[montyhedge] 13/1/2022 08:03

I see Hikma on the RSI Index most oversold share.

[montyhedge] 12/1/2022 16:04

Rns out, you can see who selling Hikma good old Blackrock.

[bigbertie] 10/1/2022 12:50

It doesn't help that most sales are in US, and Sterling has been rising against the dollar since start of December. Also pharma shares generally slippig back at the moment.

[montyhedge] 10/1/2022 12:21

Finals in February another dividend increase expected. What's that's 15 years continuous dividend growth.It's certainly a bottom draw stock, look every now and then.

[netcurtains] 10/1/2022 10:03

Montyhedge I bought it as one technical analysis site said STRONG SELL and another said BUY - so I feel it must be either on the turn NORTH or might be soon.
Its probably at a turning/deciding point.

[montyhedge] 10/1/2022 08:11

Yes, it's certain a friendless stock.Great rns and the shares went down.

[robertball] 10/1/2022 08:00

The market can be irrational longer than you can be solvent. Why this isn't £30 is beyond me. Maybe 2022 will be Hikmas year.

[montyhedge] 10/1/2022 07:38

Great rns this morning.

[blue59] 07/1/2022 13:13

Read their own website!

[scepticalinvestor] 07/1/2022 11:55

The BOD are almost all caucasian?

[blue59] 07/1/2022 11:04

It does look like a black run on Ajax Aspen!
It’s what comes with building a BoD based on diversity rather than capability!

[thamestrader] 07/1/2022 08:56

Bit steep for me, think I'll stick to the nursery slopes.

[blue59] 07/1/2022 08:53

The share price graph has just reminded me that it’s time to book a skiing holiday!

[montyhedge] 05/1/2022 15:48

Amarin skinny label suit in Vescapa against Hikma been dismissed.Good news.